The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma

The survival of patients diagnosed with metastatic renal cell carcinoma (RCC) is still limited and the current targeted therapies are only partially effective. Herein, we investigated the clinical value and functions of adiponectin receptors (AdipoR1 and AdipoR2) in metastatic renal cell carcinoma (...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Guangxi, Zhang, Xingming, Liu, Zhenhua, Zhu, Sha, Shen, Pengfei, Zhang, Haoran, Zhang, Mengni, Chen, Ni, Zhao, Jinge, Chen, Junru, Liu, Jiandong, Dai, Jindong, Wang, Zhipeng, Zhu, Xudong, Wang, Yufang, Zeng, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700451/
https://www.ncbi.nlm.nih.gov/pubmed/31401413
http://dx.doi.org/10.1016/j.neo.2019.07.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700451/
https://www.ncbi.nlm.nih.gov/pubmed/31401413
http://dx.doi.org/10.1016/j.neo.2019.07.004

Ejemplares similares